Morse E E
Ann Clin Lab Sci. 1977 Jan-Feb;7(1):68-72.
Numerous drugs and chemicals affect the function of human blood platelets. The mechanism of action of some medications is partly understood. Aspirin is the most frequently involved drug. It appears to interfere with the platelet release reaction by acetylation of a platelet membrane protein which may be involved in the synthesis of prostaglandins. Other anti-inflammatory drugs, including indomethacin, phenylbutazone, ibuprophen (Motrin) and clonixin, also interfere with the release reaction but have a shorter acting course than aspirin. Some drugs stimulate adenylcyclase (gliclazide) or block phosphodiesterase, (dipyridamole, caffeine) both of which actions lead to an increase in adenosine cyclic 3':5' monophosphate (cAMP) and decrease aggregation by adenosine diphosphate (ADP). These interactions should be known to clinical scientists since patients using these medicaments may manifest abnormal platelet function tests in the laboratory and mild hemorrhagic syndromes in the clinic.
许多药物和化学物质会影响人体血小板的功能。一些药物的作用机制已部分为人所知。阿司匹林是最常涉及的药物。它似乎通过使一种可能参与前列腺素合成的血小板膜蛋白乙酰化来干扰血小板释放反应。其他抗炎药,包括吲哚美辛、保泰松、布洛芬(Motrin)和氯尼辛,也会干扰释放反应,但作用过程比阿司匹林短。一些药物刺激腺苷酸环化酶(格列齐特)或阻断磷酸二酯酶(双嘧达莫、咖啡因),这两种作用都会导致环磷酸腺苷(cAMP)增加,并减少二磷酸腺苷(ADP)引起的聚集。临床科学家应该了解这些相互作用,因为使用这些药物的患者在实验室可能表现出异常的血小板功能测试结果,在临床上可能出现轻度出血综合征。